Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretoglobin family 1C member 2 (SCGB1C2) is a small, secreted, alpha-helical, disulfide-linked dimeric protein found only in mammals, and is thought to function predominantly in extracellular fluids[1][6][3][7]. Members of the secretoglobin family, including SCGB1C2, have been implicated in modulating inflammation, tissue repair, and potentially tumorigenesis, although the specific physiological actions and disease associations of SCGB1C2 remain poorly understood and require further study[2][6]. Its structure is homologous to other secretoglobins, featuring a dimer with a hydrophobic cavity formed at the interface, capable of binding small ligands, but its individual ligands and functional pathways have not been fully mapped[6]. SCGB1C2 is associated with inflammatory spondylopathy, reflecting a possible modulatory role in inflammation, and is mainly studied in the context of gene expression and knockout mouse phenotype models[1][5]. No drugs or therapeutic applications are currently linked to SCGB1C2[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretoglobin family 1C member 2 (SCGB1C2).